Impact of comorbidity on risk of venous thromboembolism in patients with breast cancer: A danish population-based cohort study

BMJ Open

Volumn 4, Issue 6, 2014, Pages

  Ording, Anne Gulbech ^a   Horváth Puhó, Erzsébet ^a   Garne, Jens Peter ^b   Nyström, Petra Witt ^c   Vyberg, Mogens ^b   Sørensen, Henrik Toft ^a   Lash, Timothy L ^a,d  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CARDIOVASCULAR RISK; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DENMARK; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; OBESITY; VENOUS THROMBOEMBOLISM; ADOLESCENT; BREAST TUMOR; CHILD; COMPLICATION; INFANT; MIDDLE AGED; PRESCHOOL CHILD; RISK ASSESSMENT; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DENMARK; FEMALE; HUMANS; INFANT; MIDDLE AGED; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84901950509     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-005082     Document Type: Article

References (34)

1. Lyman GH. Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis. Cancer 2011;117:1334-49.
2. Sorensen HT, Mellemkjaer L, Olsen JH, et al. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000;343:1846-50. (Pubitemid 32104130)
3. Cronin-Fenton DP, Sondergaard F, Pedersen LA, et al. Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006. Br J Cancer 2010;103:947-53.
4. Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000;160:809-15. (Pubitemid 30165241)
5. Blom JW, Doggen CJ, Osanto S, et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005;293:715-22. (Pubitemid 40216041)
6. Chew HK, Wun T, Harvey DJ, et al . Incidence of venous thromboembolism and the impact on survival in breast cancer patients. J Clin Oncol 2007;25:70-6. (Pubitemid 350003053)
7. Khorana AA, Francis CW, Culakova E, et al. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 2007;110:2339-46. (Pubitemid 350100757)
8. Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 2003;21:3665-75. (Pubitemid 46594061)
9. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
10. Cronin-Fenton DP, Norgaard M, Jacobsen J, et al. Comorbidity and survival of Danish breast cancer patients from 1995 to 2005. Br J Cancer 2007;96:1462-8. (Pubitemid 46685783)
11. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 2005;162:975-82. (Pubitemid 41619468)
12. Prandoni P, Bilora F, Marchiori A, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003;348:1435-41. (Pubitemid 36407172)
13. Breart G, Cooper C, Meyer O, et al. Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database. Osteoporos Int 2010;21:1181-7.
14. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003;107(23 Suppl 1):I9-16.
15. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83. (Pubitemid 17055592)
16. Rothman KJ, Greenland S, Lash TL. Concepts of interaction. Modern epidemiology. 3rd edn. Philadelphia: Lippincott Williams & Wilkins, 2008:71-86.
17. Tsai AW, Cushman M, Rosamond WD, et al. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med 2002;162:1182-9. (Pubitemid 34522408)
18. Lip GY, Tse HF. Management of atrial fibrillation. Lancet 2007;370:604-18. (Pubitemid 47248681)
19. Frank L. Epidemiology. When an entire country is a cohort. Science 2000;287:2398-9. (Pubitemid 30185417)
20. Pedersen CB, Gotzsche H, Moller JO, et al. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006;53:441-9. (Pubitemid 44816920)
21. Storm HH, Michelsen EV, Clemmensen IH, et al. The Danish Cancer Registry - history, content, quality and use. Dan Med Bull 1997;44:535-9.
22. Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health 2011;39(7 Suppl):42-5.
23. Andersen TF, Madsen M, Jorgensen J, et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263-8. (Pubitemid 29299976)
24. Severinsen MT, Kristensen SR, Overvad K, et al. Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J Clin Epidemiol 2010;63:223-8.
25. Andersen PK, Geskus RB, de Witte T, et al. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 2012;41:861-70.
26. Mandala M, Barni S, Prins M, et al. Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial. Ann Oncol 2010;21:871-6.
27. Degen JL, Palumbo JS. Hemostatic factors, innate immunity and malignancy. Thromb Res 2012;129(Suppl 1):S1-5.
28. Johannesdottir SA, Horvath-Puho E, Dekkers OM, et al. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med 2013;173:743-52.
29. Schmidt M, Christiansen CF, Horvath-Puho E, et al. Non-steroidal anti-inflammatory drug use and risk of venous thromboembolism. J Thromb Haemost 2011;9:1326-33.
30. Jensen AR, Overgaard J, Storm HH. Validity of breast cancer in the Danish Cancer Registry. A study based on clinical records from one county in Denmark. Eur J Cancer Prev 2002;11:359-64. (Pubitemid 34948204)
31. Thygesen SK, Christiansen CF, Christensen S, et al. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 2011;11:83.
32. Greenland S. The effect of misclassification in the presence of covariates. Am J Epidemiol 1980;112:564-9. (Pubitemid 10029558)
33. Moller S, Jensen MB, Ejlertsen B, et al. The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncol 2008;47:506-24. (Pubitemid 351878431)
34. Caine GJ, Stonelake PS, Rea D, et al. Coagulopathic complications in breast cancer. Cancer 2003;98:1578-86. (Pubitemid 37238612)